Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PHGE
PHGE logo

PHGE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Biomx Inc (PHGE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.500
1 Day change
1.08%
52 Week Range
14.710
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Biomx Inc (PHGE) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading trends, no recent news or catalysts, and bearish technical indicators suggest that this stock does not align with the user's investment goals.

Technical Analysis

The technical indicators for PHGE are bearish. The MACD is below 0 and negatively contracting, suggesting weak momentum. The RSI is neutral at 61.56, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 6.396) in the pre-market, but the overall trend remains weak.

Positive Catalysts

  • NULL. There is no recent news, no significant trading trends, and no positive financial performance to act as a catalyst.

Neutral/Negative Catalysts

  • The technical indicators are bearish, and there is no recent news or trading activity to suggest a reversal in sentiment.

Financial Performance

In Q4 2025, Biomx Inc reported no revenue growth (0% YoY), a net income decline of -8.10% YoY to -$13.34 million, and a significant drop in EPS by -45.86% YoY to -8.18. Gross margin remained at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes are available for PHGE.

Wall Street analysts forecast PHGE stock price to rise
1 Analyst Rating
Wall Street analysts forecast PHGE stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.420
sliders
Low
26
Averages
26
High
26
Current: 7.420
sliders
Low
26
Averages
26
High
26
H.C. Wainwright
Joseph Pantginis
Buy -> Neutral
downgrade
AI Analysis
2026-03-09
New
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
AI Analysis
2026-03-09
New
downgrade
Buy -> Neutral
Reason
H.C. Wainwright analyst Joseph Pantginis downgraded BiomX to Neutral from Buy. BiomX has "had a rough time as of late," says the analyst, who notes that both the CEO and Chairman of the Board resigned from the company on March 6, adding "further concern about the potential path forward for the company."
H.C. Wainwright
Joseph Pantginis
Buy
upgrade
$15 -> $26
2025-11-25
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
$15 -> $26
2025-11-25
upgrade
Buy
Reason
H.C. Wainwright analyst Joseph Pantginis adjusted the firm's price target on BiomX to $26 from $15 and keeps a Buy rating on the shares. The adjusted target follows the company's reverse stock split.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PHGE
Unlock Now

People Also Watch